Conatus Pharmaceuticals (CNAT) Earnings

Nov 2Confirmed
Mar 2018
May 2018
Aug 2018
Nov 2018
-0.2
-0.18
-0.16
-0.15

Details

Expected EPS
-0.15
Actual EPS
-0.152
Surprise EPS
-0
Surprise Percent
-1.33%

Description

⁨Conatus Pharmaceuticals⁩ (⁦CNAT⁩) has reported earnings of ⁦-0.152⁩ per share for ⁦null⁩.

0 Comments

Share your thoughts